9 months ago
APLS
AnalystsColleen KusyColleen Kusy's Stock Forecasts
AnalystsColleen Kusy
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#4292 out of 4552 analysts
Average Return
-8.39%
Win Rate
42%11 out of 26
Risk vs Reward
Poor
Good
Colleen Kusy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +150.13% | $14.94 | $37.37 | 2022-09-06 - 2023-05-04 | Buy |
Ocular Therapeutix IncOCUL | +109.97% | $3.61 | $7.58 | 2023-09-13 - 2024-04-17 | Buy |
Apellis Pharmaceuticals IncAPLS | +98.31% | $24.22 | $48.03 | 2023-07-31 - 2024-04-17 | Buy |
Surface Oncology IncSURF | +85.12% | $0.58 | $1.07 | 2023-05-03 - 2023-09-07 | Buy |
Iveric Bio IncISEE | +52.71% | $15.50 | $23.67 | 2022-03-02 - 2023-03-02 | Buy |
Colleen Kusy Analyst Color
Get additional color on Colleen Kusy's coverage of popular stocks
Colleen Kusy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oculis Holding AgOCS | 2 | Buy | $35.00 | +194.12% | Maintains | a month ago |
Oric Pharmaceuticals IncORIC | 1 | Buy | $25.00 | +156.15% | Reiterates | a month ago |
Mersana Therapeutics IncMRSN | 3 | Hold | $5.00 | +42.05% | Maintains | 2 months ago |
Nuvalent IncNUVL | 1 | Buy | $105.00 | +63.42% | Initiates Coverage On | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 4 | Buy | $81.00 | +68.64% | Reiterates | 2 months ago |
Coherus Biosciences IncCHRS | 2 | Buy | $9.00 | +318.60% | Maintains | 3 months ago |
Ocular Therapeutix IncOCUL | 3 | Buy | $18.00 | +137.47% | Reiterates | 7 months ago |
Agenus IncAGEN | 1 | Buy | $160.00 | +2,862.96% | Initiates Coverage On | 10 months ago |
Surface Oncology IncSURF | 5 | Buy | $6.00 | +460.75% | Maintains | a year ago |
Iveric Bio IncISEE | 3 | Hold | $40.00 | +0.13% | Downgrades | a year ago |
Harpoon Therapeutics IncHARP | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | a year ago |
Karyopharm Therapeutics IncKPTI | 1 | Buy | $14.00 | N/A | Maintains | 2 years ago |
Iovance Biotherapeutics IncIOVA | 2 | Buy | $34.00 | N/A | Maintains | 2 years ago |
Sab Biotherapeutics IncSABS | 1 | Buy | $230.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.